Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pharma Tech

Fresenius and WuXi team up in 37-strong biosimilar development deal

Nov 2, 2026, 4:35 PM

Read Full Article → Fresenius and WuXi team up in 37-strong biosimilar development deal

Fresenius and WuXi team up in 37-strong biosimilar development deal

Translate article text

Choose a language and wait for the translated text.

The deal covers assets that target more than €370bn in originator sales.

Fresenius and WuXi team up in 37-strong biosimilar development deal | PharmaVoice